iRhythm Technologies Inc (STU:I25)
€ 79.5 -2 (-2.45%) Market Cap: 2.51 Bil Enterprise Value: 2.71 Bil PE Ratio: 0 PB Ratio: 37.70 GF Score: 68/100

iRhythm Technologies Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 15, 2020 / 03:45PM GMT
Release Date Price: €185 (+3.93%)
David Ryan Lewis
Morgan Stanley, Research Division - MD

Good morning, everyone. And welcome to the Morgan Stanley Healthcare Conference 2020. My name is David Lewis, Medical Device Analyst here at Morgan Stanley. It's my pleasure to have with us here as we progress through the morning, iRhythm Technologies and multiple members of management here, Kevin King, President and CEO; as well as Doug Devine, recently appointed and joined CFO. Kevin has graciously offered to dispense with a preamble. So I will jump right in here with questions.

Questions & Answers

David Ryan Lewis
Morgan Stanley, Research Division - MD

And Kevin, I want to start the same place with you that I have with most of my CEO so far, this 2-days session talking about recovery, right? You have a slightly different business model than the average medical company, you're not sort of doing any specific acute care procedures. But yes, you have been impacted by COVID. Maybe talk a little about -- you talked about recovery that you're seeing in June at the time of the second quarter. What

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot